OnCore Login

Return to Trial Database

HCRN-GU15-215

A Phase II Trial of Atezolizumab and Bevacizumab in Cisplatin-ineligible Patients with Advanced/Unresectable Urothelial Cancer

Status

Study Completed

Cancer Type(s)

BladderUrothelial Carcinoma

Study Contact

Publications

A phase II trial of atezolizumab (atezo) and bevacizumab (bev) in cisplatin-ineligible patients (pts) with advanced/unresectable urothelial cancer (UC)
  • AV Balar, SA Funt, S Gupta, AZ Dudek, AR Boiles, DA Vaena, D Kilari, JE Rosenberg

Trial Locations

All sites in which the trial HCRN-GU15-215 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278